Gufic Biosciences Statistics

Total Valuation

Gufic Biosciences has a market cap or net worth of INR 44.79 billion. The enterprise value is 47.55 billion.

Market Cap	44.79B
Enterprise Value	47.55B

Important Dates

The last earnings date was Thursday, November 7, 2024.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	Sep 17, 2024

Share Statistics

Gufic Biosciences has 100.28 million shares outstanding. The number of shares has increased by 2.60% in one year.

Current Share Class	n/a
Shares Outstanding	100.28M
Shares Change (YoY)	+2.60%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	44.44%
Owned by Institutions (%)	5.86%
Float	24.75M

Valuation Ratios

The trailing PE ratio is 52.70.

PE Ratio	52.70
Forward PE	n/a
PS Ratio	5.57
PB Ratio	7.80
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 33.97, with an EV/FCF ratio of -193.06.

EV / Earnings	55.99
EV / Sales	5.92
EV / EBITDA	33.97
EV / EBIT	36.50
EV / FCF	-193.06

Financial Position

The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.52.

Current Ratio	1.63
Quick Ratio	0.93
Debt / Equity	0.52
Debt / EBITDA	2.11
Debt / FCF	-12.01
Interest Coverage	8.23

Financial Efficiency

Return on equity (ROE) is 17.60% and return on invested capital (ROIC) is 10.06%.

Return on Equity (ROE)	17.60%
Return on Assets (ROA)	7.85%
Return on Capital (ROIC)	10.06%
Revenue Per Employee	5.39M
Profits Per Employee	569,604
Employee Count	1,491
Asset Turnover	0.78
Inventory Turnover	2.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.71% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+61.71%
50-Day Moving Average	417.21
200-Day Moving Average	355.51
Relative Strength Index (RSI)	53.19
Average Volume (20 Days)	16,338

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gufic Biosciences had revenue of INR 8.04 billion and earned 849.28 million in profits. Earnings per share was 8.47.

Revenue	8.04B
Gross Profit	4.20B
Operating Income	1.30B
Pretax Income	1.14B
Net Income	849.28M
EBITDA	1.40B
EBIT	1.30B
Earnings Per Share (EPS)	8.47

Full Income Statement

Balance Sheet

The company has 193.96 million in cash and 2.96 billion in debt, giving a net cash position of -2.77 billion or -27.58 per share.

Cash & Cash Equivalents	193.96M
Total Debt	2.96B
Net Cash	-2.77B
Net Cash Per Share	-27.58
Equity (Book Value)	5.74B
Book Value Per Share	57.24
Working Capital	2.24B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 696.55 million and capital expenditures -942.87 million, giving a free cash flow of -246.32 million.

Operating Cash Flow	696.55M
Capital Expenditures	-942.87M
Free Cash Flow	-246.32M
FCF Per Share	-2.46

Full Cash Flow Statement

Margins

Gross margin is 52.28%, with operating and profit margins of 16.21% and 10.57%.

Gross Margin	52.28%
Operating Margin	16.21%
Pretax Margin	14.19%
Profit Margin	10.57%
EBITDA Margin	17.42%
EBIT Margin	16.21%
FCF Margin	-3.06%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.02%.

Dividend Per Share	0.10
Dividend Yield	0.02%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	2.33%
Buyback Yield	-2.60%
Shareholder Yield	-2.58%
Earnings Yield	1.90%
FCF Yield	-0.55%

Dividend Details

Stock Splits

The last stock split was on October 29, 2002. It was a forward split with a ratio of 10.

Last Split Date	Oct 29, 2002
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a